Literature DB >> 15225980

Tick-borne rickettsial diseases: emerging risks in Europe.

Philippe Parola1.   

Abstract

Ticks are currently considered the main vectors of human infectious diseases in Europe, particularly since their role in the transmission of the agent of Lyme borreliosis was demonstrated in the 1980s. In the recent years, ticks have also been shown to be the vectors of numerous emerging rickettsial diseases. Although Mediterranean spotted fever (MSF) due to Rickettsia conorii was thought for a long time to be the only tick-borne rickettsial disease prevalent in Europe, five more spotted fever rickettsiae have been described as emerging pathogens in the last decade. Further, cases of infection due to Anaplasma phagocytophilum, the agent of human anaplasmosis (previously known as human granulocytic ehrlichiosis), have been reported throughout Europe. We present here these emerging diseases and discuss other potential threat for the future.

Entities:  

Mesh:

Year:  2004        PMID: 15225980     DOI: 10.1016/j.cimid.2004.03.006

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  17 in total

1.  Anaplasma phagocytophilum infection in a domestic cat in Finland: Case report.

Authors:  Helka M Heikkilä; Anna Bondarenko; Andrea Mihalkov; Kurt Pfister; Thomas Spillmann
Journal:  Acta Vet Scand       Date:  2010-11-15       Impact factor: 1.695

2.  Ticks and bacterial tick-borne pathogens in Piemonte region, Northwest Italy.

Authors:  Dario Pistone; Massimo Pajoro; Eva Novakova; Nadia Vicari; Cesare Gaiardelli; Roberto Viganò; Camilla Luzzago; Matteo Montagna; Paolo Lanfranchi
Journal:  Exp Appl Acarol       Date:  2017-11-30       Impact factor: 2.132

3.  A novel approach, based on BLSOMs (Batch Learning Self-Organizing Maps), to the microbiome analysis of ticks.

Authors:  Ryo Nakao; Takashi Abe; Ard M Nijhof; Seigo Yamamoto; Frans Jongejan; Toshimichi Ikemura; Chihiro Sugimoto
Journal:  ISME J       Date:  2013-01-10       Impact factor: 10.302

4.  Characterization of Anaplasma phagocytophilum major surface protein 5 and the extent of its cross-reactivity with A. marginale.

Authors:  N I Strik; A R Alleman; A F Barbet; H L Sorenson; H L Wamsley; F P Gaschen; N Luckschander; S Wong; F Chu; J E Foley; A Bjoersdorff; S Stuen; D P Knowles
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

5.  16S rRNA gene-based identification of midgut bacteria from field-caught Anopheles gambiae sensu lato and A. funestus mosquitoes reveals new species related to known insect symbionts.

Authors:  Jenny M Lindh; Olle Terenius; Ingrid Faye
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

Review 6.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

7.  Ectoparasites of dogs and cats in Albania.

Authors:  Dashamir Xhaxhiu; Ilir Kusi; Dhimiter Rapti; Martin Visser; Martin Knaus; Thomas Lindner; Steffen Rehbein
Journal:  Parasitol Res       Date:  2009-08-19       Impact factor: 2.289

8.  Ticks infesting livestock on farms in Western Sicily, Italy.

Authors:  Alessandra Torina; Cristina Khoury; Santo Caracappa; Michele Maroli
Journal:  Exp Appl Acarol       Date:  2006       Impact factor: 2.132

9.  Anaplasma phagocytophilum, Sardinia, Italy.

Authors:  Alberto Alberti; Maria Filippa Addis; Olivier Sparagano; Rosanna Zobba; Bernardo Chessa; Tiziana Cubeddu; Maria Luisa Pinna Parpaglia; Mauro Ardu; Marco Pittau
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

10.  Zoonotic transmission of pathogens by Ixodes ricinus ticks, Romania.

Authors:  Oana Alina Paduraru; Jean Philippe Buffet; Martine Cote; Sarah Bonnet; Sarah Moutailler; Vlad Paduraru; Françoise Femenia; Marc Eloit; Gheorghe Savuta; Muriel Vayssier-Taussat
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.